We first analyzed the data of Wu et al. [12] detailing specific GNAS and KRAS mutation status in IPMN samples (cyst fluid and micro-dissected cyst wall specimens) of 132 patients. The gene discussed is KRAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.